Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone.

Swanson JW, Swartz MS, Elbogen EB, Van Dorn RA.

J Clin Psychiatry. 2004 Dec;65(12):1666-73.

PMID:
15641872
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
4.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241
5.

Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

Dossenbach M, Arango-Dávila C, Silva Ibarra H, Landa E, Aguilar J, Caro O, Leadbetter J, Assunção S.

J Clin Psychiatry. 2005 Aug;66(8):1021-30.

PMID:
16086618
6.

Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.

Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.

J Psychiatr Res. 2006 Oct;40(7):669-76. Epub 2006 Jun 9.

PMID:
16762371
7.

Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan.

Ye W, Fujikoshi S, Nakahara N, Takahashi M, Ascher-Svanum H, Ohmori T.

Psychiatry Clin Neurosci. 2012 Jun;66(4):313-21. doi: 10.1111/j.1440-1819.2012.02351.x.

8.

Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.

Takahashi H, Kamata M, Yoshida K, Ishigooka J, Higuchi H.

J Clin Psychiatry. 2006 Oct;67(10):1577-82.

PMID:
17107250
9.

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.

Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I; IC-SOHO Study Group.

J Clin Psychiatry. 2004 Mar;65(3):312-21.

PMID:
15096069
10.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
11.

Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.

Opolka JL, Rascati KL, Brown CM, Gibson PJ.

Psychiatr Serv. 2004 Feb;55(2):151-6.

PMID:
14762239
12.

Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.

Sevy S, Robinson DG, Sunday S, Napolitano B, Miller R, McCormack J, Kane J.

Psychiatry Res. 2011 Aug 15;188(3):310-4. doi: 10.1016/j.psychres.2011.05.001. Epub 2011 Jun 1.

13.

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).

García-Cabeza I, Gómez JC, Sacristán JA, Edgell E, González de Chavez M.

BMC Psychiatry. 2001;1:7. Epub 2001 Dec 28.

14.

Adherence to conventional and atypical antipsychotics after hospital discharge.

Diaz E, Neuse E, Sullivan MC, Pearsall HR, Woods SW.

J Clin Psychiatry. 2004 Mar;65(3):354-60.

PMID:
15096075
15.

A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia.

Ho BC, Miller D, Nopoulos P, Andreasen NC.

J Clin Psychiatry. 1999 Oct;60(10):658-63.

PMID:
10549681
16.

Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.

[No authors listed]

Br J Psychiatry Suppl. 1996 Dec;(31):21-30. Review. No abstract available.

PMID:
8968652
17.

Changes in neuropsychological functioning following treatment with risperidone, olanzapine, and conventional antipsychotic medications.

Jerrell JM, Ramirez PM.

Hum Psychopharmacol. 2008 Oct;23(7):595-604. doi: 10.1002/hup.967.

PMID:
18680213
18.
19.

[Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study].

Mayoral F, Montejo AL, Bousoño M, González-Torres MA, Olivares JM, Ros S, Sanjuán J, Escobar R, Lara N.

Actas Esp Psiquiatr. 2006 Jan-Feb;34(1):7-15. Spanish.

PMID:
16525900
20.

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.

Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, García-Portilla MP, Fernández I, Hernández G; EIRE Study Group.

Schizophr Res. 2003 Jul 1;62(1-2):77-88.

PMID:
12765747

Supplemental Content

Support Center